Life Sciences
- Services
- Key Diseases
  - NASH
  - COVID-19
  - CVD
  - diabetes
- Resources
  - Whitepapers
  - Webinars
  - Posters
  - Blog
Healthcare Systems
Patients & Providers
Payers
Technology
Company
Investors

Life Sciences
- Services
- Key Diseases
  - NASH
  - COVID-19
  - CVD
  - diabetes
- Resources
  - Whitepapers
  - Webinars
  - Posters
  - Blog
Healthcare Systems
Patients & Providers
Payers
Technology
Company
Investors

Typical protein assays
measure, at most, 10%
of the human proteome

With the SomaScan^® Assay,
you can measure 7,000 proteins
from 55μl of blood.

That's 350% more
than our nearest competitor.

Genome-wide pathway overview

Go deeper with SomaScan Proteomics

Download the Tech Note

Explore Services

Get Updates

reproducible

Because the SomaScan Assay does not rely on polyclonal antibodies, which are variable, SomaScan

data achieves coefficients of variation much lower than industry standards. Additionally, it is the only platform

that can be seamlessly used for the entire biomarker research pipeline from discovery to development consistently over time.

SPECIFICITY

While most protein assays rely on a variation of the ELISA sandwich approach, the SomaScan Assay relies on kinetics: non-specific interactions dissociate faster. Tests have confirmed minimal cross-reactivity with closely related proteins.

DYNAMIC RANGE

A tiered dilution approach is used to measure proteins of very high abundance and very low abundance separately, such that a total range of 10 logs can be measured from just 55 μl of plasma or serum.

MENU SIZE

The largest commercial proteomic assay on the market,

providing over 7,000 protein measurements.

Breakdown of proteins on the SomaScan® Assay for which biological pathways are

known (chart generated via the PANTHER classification system http://pantherdb.org/)

SENSITIVITY

The tiered approach used for SomaScan measurements enables the

detection of very rare proteins consistently without sample pre-treatment.

Reference: Created via FoamTree using the ReacFoam genome-wide pathway overview provided under license to EMBL-EBI by Carrot Search, Inc. (abregat A, Sidiropoulos K, Viteri G, Marin-Garcia P, Ping P, Stein L, D’Eustachio P, Hermjakob H. Reactome diagram viewer: data structures and strategies to boost performance. Bioinformatics (Oxford, England). 2018 Apr;34(7) 1208-1214. doi: 10.1093/bioinformatics/btx752. PubMed PMID: 29186351. PubMed Central PMCID: PMC6030826.)

Typical protein assays measure, at most, 10% of the human proteome

With the SomaScan® Assay, you can measure 7,000 proteins from 55μl of blood.

That's 350% morethan our nearest competitor.

Genome-wide pathway overview

Typical protein assays
measure, at most, 10%
of the human proteome

With the SomaScan^® Assay,
you can measure 7,000 proteins
from 55μl of blood.

That's 350% more
than our nearest competitor.